NanoPhoria Bioscience has announced the second closing of its series A financing round, including a €15 million equity investment from the European Innovation Council (EIC) Fund. The company recently received the largest ever Series A financing round in Italian biotech history, Alongside the EIC, NanoPhoria also received… Read More
Sergio Marullo di Condojanni has been appointed Chief Executive Officer of Italian pharma company Angelini Pharma. Di Condojanni has served as CEO of Angelini Industries since 2020 and will maintain that role while assuming leadership of the pharmaceutical division to drive the company’s strategy implementation, leveraging extensive executive, governance, and financial expertise. Angelini Pharma,… Read More
Italian research institute and contract research organisation IRBM has become the only company from outside the United States to join cancer drug discovery network the Chemical Biology Consortium (CBC). The CBC is the discovery engine of the National Cancer Institute (NCI) Experimental Therapeutics (NExT) Program, administered… Read More
